CompletedPhase 1NCT01471067
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
Studying B-lymphoblastic leukemia/lymphoma with hypodiploidy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Elizabeth Shpall, MD, M.DM.D. Anderson Cancer Center
- Intervention
- Melphalan(drug)
- Enrollment
- 33 enrolled
- Eligibility
- 1-80 years · All sexes
- Timeline
- 2012 – 2017
Study locations (1)
- University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Collaborators
American Stem Cell, Inc. · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01471067 on ClinicalTrials.gov